. Safety and tolerability of GRF6019 in mild-to-moderate Alzheimer's disease dementia. Alzheimers Dement (N Y). 2020;6(1):e12115. Epub 2020 Dec 16 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. GRF6019